Novavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax’s COVID-19 vaccine and take a minority stake in the struggling biotech company. The deal gave Novavax a much-needed cash boost as the company had flagged after a pandemic-era…

Read more →